Science Explorer Interactive view Map
Company · Madison · United States

Leo Pharma (United States)

leo-pharma.usROR OpenAlex
Research works
18
▲ 1484% vs 2013–17
Citations
51
2.8 per fractional work
Top-10% rate
10.9%
record average 16.5%
Open access
74%
world 28%

Not ranked overall: Leo Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.44× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 10.39× its world share, 1 worksImmunology and Micro…Neuroscience: 0.21× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.95× its world share, 0 worksPharmacology, Toxico…Environmental Science: 0.54× its world share, 0 worksEnvironmental ScienceHealth Professions: 1.27× its world share, 0 worksHealth ProfessionsMedicine: 4.12× its world share, 10 worksMedicineEconomics, Econometrics and Finance: 0.63× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.4×. Every wedge is a field page.

Which research topics does Leo Pharma (United States) publish most on?

By volume in 2022–2025: Dermatology and Skin Diseases, Asthma and respiratory diseases, Urticaria and Related Conditions and Contact Dermatitis and Allergies.

Dermatology and Skin Dis…4Dermatology and Skin Diseases: 4 fractional worksAsthma and respiratory diseases: 1 fractional worksUrticaria and Related Conditions: 1 fractional worksContact Dermatitis and Allergies: 1 fractional worksPsoriasis: Treatment and…1Psoriasis: Treatment and Pathogenesis: 1 fractional worksFood Allergy and Anaphylaxis Research: 1 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksNail Diseases and Treatments: 0 fractional worksIL-33, ST2, and ILC Pathways: 0 fractional works
DermatologyPhysiologyRheumatologyImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 4 works
  2. 2 Asthma and respiratory diseases Physiology 1 works
  3. 3 Urticaria and Related Conditions Rheumatology 1 works
  4. 4 Contact Dermatitis and Allergies Dermatology 1 works
  5. 5 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  6. 6 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  7. 7 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 0 works
  9. 9 Nail Diseases and Treatments Epidemiology 0 works
  10. 10 IL-33, ST2, and ILC Pathways Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available74.0%not open26.0%

World: 28% of research is openly available.

with international co-authors60.3%domestic only39.7%

World: 19% is written across borders.

How has Leo Pharma (United States)'s research output changed?

Output in 2018–2022 was 1484% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madison

All research institutions in Madison

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.